- Home
- CARV vs XXII Comparison
CARV vs XXII Comparison
Compare CARV & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARV
- XXII
- Stock Information
- Founded
- CARV 1948
- XXII 1998
- Country
- CARV United States
- XXII United States
- Employees
- CARV N/A
- XXII N/A
- Industry
- CARV Savings Institutions
- XXII Medicinal Chemicals and Botanical Products
- Sector
- CARV Finance
- XXII Health Care
- Exchange
- CARV Nasdaq
- XXII Nasdaq
- Market Cap
- CARV 7.3M
- XXII 7.0M
- IPO Year
- CARV 1994
- XXII N/A
- Fundamental
- Price
- CARV $1.41
- XXII $0.74
- Analyst Decision
- CARV
- XXII
- Analyst Count
- CARV 0
- XXII 0
- Target Price
- CARV N/A
- XXII N/A
- AVG Volume (30 Days)
- CARV 20.0K
- XXII 289.5K
- Earning Date
- CARV 07-15-2025
- XXII 05-13-2025
- Dividend Yield
- CARV N/A
- XXII N/A
- EPS Growth
- CARV N/A
- XXII N/A
- EPS
- CARV N/A
- XXII N/A
- Revenue
- CARV $24,056,000.00
- XXII $23,869,000.00
- Revenue This Year
- CARV N/A
- XXII $22.41
- Revenue Next Year
- CARV N/A
- XXII $76.35
- P/E Ratio
- CARV N/A
- XXII N/A
- Revenue Growth
- CARV N/A
- XXII N/A
- 52 Week Low
- CARV $1.30
- XXII $0.70
- 52 Week High
- CARV $2.39
- XXII $140.40
- Technical
- Relative Strength Index (RSI)
- CARV 50.30
- XXII 32.55
- Support Level
- CARV $1.35
- XXII $0.72
- Resistance Level
- CARV $1.50
- XXII $0.77
- Average True Range (ATR)
- CARV 0.09
- XXII 0.06
- MACD
- CARV -0.01
- XXII -0.01
- Stochastic Oscillator
- CARV 30.00
- XXII 5.25
About CARV Carver Bancorp Inc.
Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.